Overview
Tectonic is transforming the discovery of novel GPCR-targeted therapies
GPCRs whose natural ligands are peptides or proteins represent large untapped opportunities, best addressed with a biologic approach. Our science
unlocks the therapeutic utility of the most difficult receptors in the class, to date considered undruggable with small molecule.